These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11386652)

  • 1. Adrenal suppression and growth retardation from ocular corticosteroids.
    Steelman J; Kappy M
    J Pediatr Ophthalmol Strabismus; 2001; 38(3):177-8. PubMed ID: 11386652
    [No Abstract]   [Full Text] [Related]  

  • 2. Exogenous Cushing's syndrome and topical ocular steroids.
    Chiang MY; Sarkar M; Koppens JM; Milles J; Shah P
    Eye (Lond); 2006 Jun; 20(6):725-7. PubMed ID: 16294208
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome caused by unsupervised use of ocular glucocorticoids.
    Afandi B; Toumeh MS; Saadi HF
    Endocr Pract; 2003; 9(6):526-9. PubMed ID: 14715481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
    Mendilaharzu H; Gregory T; Gardner LI
    J Pediatr; 1973 Jul; 83(1):69-76. PubMed ID: 4358656
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them.
    Lansang MC; Hustak LK
    Cleve Clin J Med; 2011 Nov; 78(11):748-56. PubMed ID: 22049542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid hypertension.
    Pletka PG; Hickler RB
    Cardiovasc Clin; 1978; 9(1):99-111. PubMed ID: 208771
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenal Suppression in Infants Treated with Topical Ocular Glucocorticoids.
    Bangsgaard R; Main KM; Boberg-Ans G; la Cour M; Forman JL; Haargaard B; Kiilgaard JF
    Ophthalmology; 2018 Oct; 125(10):1638-1643. PubMed ID: 29934270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pathological anatomy of pemphigus in connection with its treatment with steroid hormones].
    Vasil'eva NN
    Arkh Patol; 1968; 30(6):45-51. PubMed ID: 4301202
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis.
    Ozerdem U; Levi L; Cheng L; Song MK; Scher C; Freeman WR
    Am J Ophthalmol; 2000 Aug; 130(2):240-1. PubMed ID: 11004305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine disorders in a polymedicated patient].
    Espiard S; Balavoine AS; Mouton F; Fry S; Vantyghem MC; Wémeau JL
    Presse Med; 2013 Mar; 42(3):378-81. PubMed ID: 22459988
    [No Abstract]   [Full Text] [Related]  

  • 11. Exogenous Cushing syndrome from an unexpected source of systemic steroids.
    O'Brien KF; DeKlotz CMC; Silverman RA
    Pediatr Dermatol; 2018 May; 35(3):e196-e197. PubMed ID: 29574945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
    Goto M; Miyagawa N; Kikunaga K; Miura M; Hasegawa Y
    Endocr J; 2015; 62(2):145-51. PubMed ID: 25342092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basis of antiphlogistic and immunosuppressive therapy with corticosteroids].
    Schulz G; Beyer J
    Dtsch Med Wochenschr; 1978 Dec; 103(48):1925-30. PubMed ID: 213250
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenocorticotropic hormone and dehydroepiandrosterone sulfate levels of rheumatoid arthritis patients treated with glucocorticoids.
    Yukioka M; Komatsubara Y; Yukioka K; Toyosaki-Maeda T; Yonenobu K; Ochi T
    Mod Rheumatol; 2006; 16(1):30-5. PubMed ID: 16622721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin after corticosteroids in children with asthma and growth retardation.
    Drever JC; Malone DN; Grant IW; Douglas DM; Lutz W
    Br J Dis Chest; 1975 Jul; 69():188-94. PubMed ID: 172098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications in glucocorticoid treatment].
    Kuralesin MG
    Med Sestra; 1981 Feb; 40(2):48-50. PubMed ID: 6907646
    [No Abstract]   [Full Text] [Related]  

  • 17. Caveat emptor.
    Hosein N; Brown T
    Am J Med; 2009 Mar; 122(3):236-8. PubMed ID: 19272482
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal venous sampling in a patient with adrenal Cushing syndrome.
    Builes-Montaño CE; Villa-Franco CA; Román-Gonzalez A; Velez-Hoyos A; Echeverri-Isaza S
    Colomb Med (Cali); 2015; 46(2):84-7. PubMed ID: 26309345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal suppression and growth retardation after injection of periocular capillary hemangioma with corticosteroids.
    Glatt HJ; Putterman AM; Van Aalst JJ; Levine MR
    Ophthalmic Surg; 1991 Feb; 22(2):95-7. PubMed ID: 2038483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal suppression with cushingoid features from inhaled corticosteroid therapy in an adult asthmatic patient.
    Tsoukas MA; Krishnamoorthy P; Richards BJ; Pepe C; Christopoulos S
    Am J Med; 2014 May; 127(5):e1-2. PubMed ID: 24412770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.